All In MedTech

FDA Clearance Tracker · P020024-S067

Amplatzer Piccolo™ Occluder

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Mar 27, 2023 (this decision)Source: openFDAMethods & limitations

PMA supplement

The decision

FDA number
P020024-S067
Device name
Amplatzer Piccolo™ Occluder
Applicant location
St. Paul, MN
Received
Nov 4, 2022
Decided
Mar 27, 2023
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Labeling Change - PAS
Original approval
P020024

Device type

Device class
Class III

Every decision under product code MAE

FDA's approval statement

As written in FDA's record.

Approval for modifications to the Instructions for Use to include the 3-year follow up data on patients enrolled in the ADO II AS Clinical Study (IDE and Continued Access Cohorts).

Source documents

Other decisions for ABBOTT MEDICAL

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.